CSPC Subsidiary Awarded Provincial Engineering Research Center
January 11, 2024
Share:
Recently, the Shandong Development and Reform Commission announced the list (the second batch) of Shandong engineering research centers included in new sequence management. Shandong Engineering Research Center for Long-acting Protein Drugs, established by the CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. ("CSPC Baike"), was on the list.
The Center has a domestic first-class protein site-specific modification technology platform and research and development team, as well as a complete system for biological drug research, development, and achievement transformation.
In recent years, the Center has undertaken over 10 national, provincial, and municipal science and technology programs and has completed the research, development, and industrialization of blockbuster new drugs, such as the national Class I biological product, PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor Injection (trade name: Jinyouli). The program has won the National Patent Gold Award, the Second Prize of the National Science and Technology Progress Award, and the China Grand Awards for Industry-Recognition Award.
